Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06425380 · ClinicalTrials.gov registry record · NA

Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

A NA study of Cirrhosis and Hepatic Encephalopathy, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
11
Enrollment target
2
Study locations

NCT06425380 is a NA study of Cirrhosis and Hepatic Encephalopathy that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 11 participants, below the 90,409-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06425380, a NA study of Cirrhosis and Hepatic Encephalopathy, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
11 participants
Enrollment target
2
Study locations

Study Summary

This research is studying how a food product (resistant potato starch) which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy. The researchers in this study want to understand how potato starch works in the subject's body and how the body will react to it. Along with taking the study product participants health-related information and stool will be collected for this research study.

Conditions Studied

Cirrhosis Hepatic Encephalopathy

Interventions

  • OTHER Resistant Potato Starch

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester
  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2024-07-12
Est. Completion 2027-01-28
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06425380

The ClinicalTrials.gov registry entry for NCT06425380 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,409-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which Resistant Potato Starch is the first listed.

NCT06425380 reports 2 study locations spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06425380 about?

NCT06425380 is a clinical study titled "Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy". This research is studying how a food product (resistant potato starch) which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy. The researchers in this study want to understand how potato starch works in the subject's body a...

What is the current status of trial NCT06425380?

This trial is currently recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2024-07-12. Estimated completion is 2027-01-28.

What conditions does trial NCT06425380 study?

This clinical trial studies the following conditions: Cirrhosis, Hepatic Encephalopathy.

What interventions are being tested in trial NCT06425380?

The interventions under investigation include: Resistant Potato Starch (OTHER).

Who is sponsoring clinical trial NCT06425380?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06425380 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cirrhosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cirrhosis

All registered trials for this condition

Hepatic Encephalopathy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.